China SXT Pharmaceuticals, Inc.
SXTC
$0.09
-$0.01-5.62%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.09% | 15.09% | 51.09% | 51.09% | 61.47% |
| Total Receivables | 77.92% | 77.92% | 41.13% | 41.13% | 25.34% |
| Inventory | 15.77% | 15.77% | 39.43% | 39.43% | 173.28% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -88.79% | -88.79% | 347.06% | 347.06% | 68.49% |
| Total Current Assets | 18.44% | 18.44% | 49.62% | 49.62% | 62.93% |
|
|
|||||
| Total Current Assets | 18.44% | 18.44% | 49.62% | 49.62% | 62.93% |
| Net Property, Plant & Equipment | -31.77% | -31.77% | -37.10% | -37.10% | -58.58% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -46.54% | -46.54% | -38.22% | -38.22% | -29.33% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -14.98% | -14.98% | -6.33% | -6.33% | 112.49% |
|
|
|||||
| Total Accounts Payable | -68.08% | -68.08% | -9.47% | -9.47% | 26.35% |
| Total Accrued Expenses | 21.14% | 21.14% | 12.00% | 12.00% | -17.33% |
| Short-term Debt | -89.76% | -89.76% | -78.85% | -78.85% | 199.40% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 73.67% | 73.67% | -12.06% | -12.06% | -47.96% |
| Total Finance Division Other Current Liabilities | -14.95% | -14.95% | -12.57% | -12.57% | 6.45% |
| Total Other Current Liabilities | -14.95% | -14.95% | -12.57% | -12.57% | 6.45% |
| Total Current Liabilities | -61.94% | -61.94% | -32.46% | -32.46% | 70.26% |
|
|
|||||
| Total Current Liabilities | -61.94% | -61.94% | -32.46% | -32.46% | 70.26% |
| Long-Term Debt | -36.60% | -36.60% | -17.76% | -17.76% | 8.16% |
| Short-term Debt | -89.76% | -89.76% | -78.85% | -78.85% | 199.40% |
| Capital Leases | -53.37% | -53.37% | -34.99% | -34.99% | -10.83% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -61.66% | -61.66% | -32.33% | -32.33% | 67.82% |
|
|
|||||
| Common Stock & APIC | 34.70% | 34.70% | 12.26% | 12.26% | 9.93% |
| Retained Earnings | -34.76% | -34.76% | -13.37% | -13.37% | 18.51% |
| Treasury Stock & Other | -34.82% | -34.82% | -4.84% | -4.84% | 44.16% |
| Total Common Equity | 34.58% | 34.58% | 10.84% | 10.84% | 196.18% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 34.58% | 34.58% | 10.84% | 10.84% | 196.18% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 34.58% | 34.58% | 10.84% | 10.84% | 196.18% |
|
|
|||||